補(bǔ)體因子B(CFB)多克隆抗體
Polyclonal Antibody to Complement Factor B (CFB)
CF-B; BF; BFD; CFAB; GBG; H2-Bf; PBF2; B-Factor; Properdin; Properdin factor B; C3/C5 convertase; Glycine-rich beta glycoprotein
- 編號PAC011Ra04
- 物種Rattus norvegicus (Rat,大鼠)相同的名稱,不同的物種。
- 來源多抗制備
- 宿主兔
- 效價(jià)-
- Ig類型IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原RPC011Ra04-補(bǔ)體因子B(CFB)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù),請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價(jià)格¥ 684 ¥ 1596¥ 2280¥ 5700¥ 22800
- 欲了解實(shí)際交易價(jià)格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
特異性
該抗體是針對CFB的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識別CFB。
用法
Western blotting: 0.5-2μg/mL;1:500-2000
Immunohistochemistry: 5-20μg/mL;1:50-200
Immunocytochemistry: 5-20μg/mL;1:50-200
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
贈(zèng)品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽性對照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長臂生物素標(biāo)記試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Rattus norvegicus (Rat,大鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPC011Ra02 | 補(bǔ)體因子B(CFB)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPC011Ra04 | 補(bǔ)體因子B(CFB)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPC011Ra01 | 補(bǔ)體因子B(CFB)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPC011Ra03 | 補(bǔ)體因子B(CFB)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAC011Ra02 | 補(bǔ)體因子B(CFB)多克隆抗體 | WB; IHC |
PAC011Ra04 | 補(bǔ)體因子B(CFB)多克隆抗體 | WB; IHC; ICC; IP. |
PAC011Ra03 | 補(bǔ)體因子B(CFB)多克隆抗體 | WB; IHC; ICC; IP. |
PAC011Ra01 | 補(bǔ)體因子B(CFB)多克隆抗體 | WB; IHC; ICC; IP. |
LAC011Ra71 | 補(bǔ)體因子B(CFB)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
SEC011Ra | 補(bǔ)體因子B(CFB)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMC011Ra | 補(bǔ)體因子B(CFB)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
BMC Nephrology | Complement in patients receiving maintenance hemodialysis: functional screening and quantitative analysis[BioMed: 14712369] |
J. Proteome Res. | Identification and Confirmation of Differentially Expressed Fucosylated Glycoproteins in the Serum of Ovarian Cancer Patients Using a Lectin Array and LC–MS/MS[ACS: pr300330z] |
Pediatr Int | Atypical hemolytic uremic syndrome: Korean pediatric series[PubMed: 25443527] |
Journal of Neuroimmunology | Acute and prolonged complement activation in the central nervous system during herpes simplex encephalitis[Pubmed:27235358] |
Biochemical and Biophysical Research Communications | Adipose tissue complement factor B promotes adipocyte maturation.[pubmed:29137982] |
Journal?of?proteome?research | Serum exosomes from newborn piglets restrict porcine epidemic diarrhea virus infection[] |
journal of human genetics | Identification of susceptibility locus shared by IgA nephropathy and inflammatory bowel disease in a Chinese Han population[Pubmed: 31857673] |
Nephrol Dial Transplant | Association between thrombotic microangiopathy and activated alternative complement pathway in malignant nephrosclerosis[33367879] |
JOURNAL OF GENERAL VIROLOGY | Changes in complement alternative pathway components, factor B and factor H during dengue virus infection in the AG129 mouse[33410734] |
J Proteome Res | Early Diagnostic Ability of Human Complement Factor B in Pancreatic Cancer Is Partly Linked to Its Potential Tumor-Promoting Role[34766501] |
J Clin Med | A Three-Protein Panel to Support the Diagnosis of Sepsis in Children[Pubmed:35329889] |